US Bancorp
TVRD

US Bancorp’s Tvardi Therapeutics TVRD Stock Holding History

US Bancorp’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1
Closed -$11 – 4287
2024
Q3 		$11 Hold
1
– – ﹤0.01% 4066
2024
Q2 		$9 Hold
1
– – ﹤0.01% 3960
2024
Q1 		$32 Hold
1
– – ﹤0.01% 3939
2023
Q4 		$26 Hold
1
– – ﹤0.01% 3940
2023
Q3 		$59 Hold
1
– – ﹤0.01% 3947
2023
Q2 		$99 Sell
1
-3
-75% -$413 ﹤0.01% 3942
2023
Q1 		$707 Sell
4
-3
-43% -$1K ﹤0.01% 3914
2022
Q4 		$2.81K Hold
7
– – ﹤0.01% 3688
2022
Q3 		$2K Buy
7
+6
+600% +$2.17K ﹤0.01% 3879
2022
Q2 		$0 Hold
1
– – ﹤0.01% 4268
2022
Q1 		$0 Hold
1
– – ﹤0.01% 4231
2021
Q4 		$0 Sell
1
-1
-50% -$502 ﹤0.01% 4251
2021
Q3 		$1K Hold
2
– – ﹤0.01% 4035
2021
Q2 		$1K Buy
+2
New +$1.27K ﹤0.01% 3959
2020
Q4 		– Sell
-6
Closed -$3K – 3905
2020
Q3 		$3K Hold
6
– – ﹤0.01% 3449
2020
Q2 		$3K Hold
6
– – ﹤0.01% 3457
2020
Q1 		$3K Sell
6
-27
-82% -$14.7K ﹤0.01% 3407
2019
Q4 		$19K Hold
33
– – ﹤0.01% 2911
2019
Q3 		$22K Sell
33
-28
-46% -$23.3K ﹤0.01% 2808
2019
Q2 		$48K Hold
61
– – ﹤0.01% 2547
2019
Q1 		$44K Hold
61
– – ﹤0.01% 2544
2018
Q4 		$29K Buy
61
+28
+85% +$18.1K ﹤0.01% 2681
2018
Q3 		$29K Buy
33
+19
+136% +$13.7K ﹤0.01% 2802
2018
Q2 		$10K Hold
14
– – ﹤0.01% 3144
2018
Q1 		$6K Buy
14
+11
+367% +$5.33K ﹤0.01% 3297
2017
Q4 		$1K Hold
3
– – ﹤0.01% 3560
2017
Q3 		$1K Sell
3
-14
-82% -$7.01K ﹤0.01% 3521
2017
Q2 		$10K Buy
+17
New +$10.8K ﹤0.01% 3066

Other funds holding TVRD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

US Bancorp's TVRD Position: Q4 2024 in Review

US Bancorp sold out of Tvardi Therapeutics (TVRD) in Q4 2024, closing a stake of 1 share — an estimated $11 sold.

US Bancorp first reported a position in TVRD in Q2 2017 and held it in 28 quarters. The position peaked at $48K in Q2 2019. 43 funds tracked by Wall St. Rank hold TVRD as of Q4 2024.

  • US Bancorp reported no remaining Tvardi Therapeutics position as of Q4 2024 after selling out during the quarter.
  • US Bancorp sold 1 Tvardi Therapeutics share in Q4 2024, an estimated $11.
  • US Bancorp first reported a position in Tvardi Therapeutics in Q2 2017 and held it in 28 quarters.
  • US Bancorp's Tvardi Therapeutics position peaked at $48K in Q2 2019.
  • 43 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q4 2024.

Based on US Bancorp's 13F filing for Q4 2024, filed 5 Feb 2025.